Skip to content
HomeOur CompanyDiscover J&JOur leadership teamMark A. Weinberger
A headshot of Mark A. Weinberger, Former Global Chairman and Chief Executive Officer, EY (Ernst & Young)

Mark A. Weinberger

Former Global Chairman and Chief Executive Officer, EY (Ernst & Young)

Mr. Weinberger, age 62, served as the Global Chairman and Chief Executive Officer of EY (Ernst & Young) (professional services) from 2013 through June 2019, having served as Global Chairman and CEO-elect in the prior year. He was Assistant Secretary of the U.S. Treasury in the George W. Bush Administration and was appointed by President Bill Clinton to serve on the U.S. Social Security Administration Advisory Board. Mr. Weinberger serves as a Senior Advisor to Stone Canyon Industries Holdings Inc. and Teneo. He is an Executive Advisor to G100 and World 50. Mr. Weinberger also serves as a Strategic Advisor to the Board of FCLTGlobal, which focuses on long-term investing and corporate governance. Mr. Weinberger is on the Board of Directors of JUST Capital. He sits on the Board of Directors of the National Bureau of Economic Research (NBER), is a Senior Advisor to Chief Executives for Corporate Purpose (CECP). He is a member of the Boards of Trustees for Emory University, Case Western Reserve University, The Concord Coalition and The Greater Washington Partnership.

Skills and Qualifications

  • Experience leading a global business and working at the highest levels of government
  • Track record of driving transformative change in the public and private sectors during periods of unprecedented disruption
  • Expertise in finance, accounting, compliance and corporate governance, with a strong commitment to corporate purpose

Current Committees

  • Chair, Regulatory Compliance & Sustainability
  • Member, Audit

Other Public Board Service

  • JPMorgan Chase & Co. (since 2024)
  • MetLife Inc. (since 2019)
  • Saudi Aramco (since 2019)
  • Accelerate Acquisition Corp. (2021 – 2022)

Board of Directors

You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.